• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

PLoS One . Long Covid active case finding study protocol: A co-produced community-based pilot within the STIMULATE-ICP study (Symptoms, Trajectory,

tetano

Editor, Senior Moderator
PLoS One


. 2023 Jul 20;18(7):e0284297.
doi: 10.1371/journal.pone.0284297. eCollection 2023. Long Covid active case finding study protocol: A co-produced community-based pilot within the STIMULATE-ICP study (Symptoms, Trajectory, Inequalities and Management: Understanding Long-COVID to Address and Transform Existing Integrated Care Pathways)

Nisreen A Alwan[SUP] 1 2 3 [/SUP], Donna Clutterbuck[SUP] 1 [/SUP], Marija Pantelic[SUP] 4 5 [/SUP], Jasmine Hayer[SUP] 6 [/SUP], Lere Fisher[SUP] 6 [/SUP], Lyth Hishmeh[SUP] 6 [/SUP], Melissa Heightman[SUP] 7 [/SUP], Gail Allsopp[SUP] 8 [/SUP], Dan Wootton[SUP] 9 10 [/SUP], Asad Khan[SUP] 6 11 [/SUP], Claire Hastie[SUP] 6 12 [/SUP], Monique Jackson[SUP] 6 [/SUP], Clare Rayner[SUP] 6 [/SUP], Darren Brown[SUP] 6 13 14 [/SUP], Emily Parrett[SUP] 6 [/SUP], Geraint Jones[SUP] 6 [/SUP], Kerry Smith[SUP] 6 [/SUP], Rowan Clarke[SUP] 6 [/SUP], Sammie Mcfarland[SUP] 6 15 [/SUP], Mark Gabbay[SUP] 16 17 [/SUP], Amitava Banerjee[SUP] 18 [/SUP]; STIMULATE-ICP Consortium



Affiliations
Abstract

Background and aim: Long Covid is a significant public health concern with potentially negative implications for health inequalities. We know that those who are already socially disadvantaged in society are more exposed to COVID-19, experience the worst health outcomes and are more likely to suffer economically. We also know that these groups are more likely to experience stigma and have negative healthcare experiences even before the pandemic. However, little is known about disadvantaged groups' experiences of Long Covid, and preliminary evidence suggests they may be under-represented in those who access formal care. We will conduct a pilot study in a defined geographical area in London, United Kingdom to test the feasibility of a community-based approach of identifying Long Covid cases that have not been clinically diagnosed and have not been referred to Long Covid specialist services. We will explore the barriers to accessing recognition, care, and support, as well as experiences of stigma and perceived discrimination.
Methods: This protocol and study materials were co-produced with a Community Advisory Board (CAB) made up primarily of people living with Long Covid. Working with voluntary organisations, a study leaflet will be distributed in the local community to highlight Long Covid symptoms and invite those experiencing them to participate in the study if they are not formally diagnosed. Potential participants will be assessed according to the study's inclusion criteria and offered the opportunity to participate if they fit them. Awareness of Long Covid and associated symptoms, experiences of trying to access care, as well as stigma and discrimination will be explored through qualitative interviews with participants. Upon completion of the interviews, participants will be offered a referral to the local social prescribing team to receive support that is personalised to them potentially including, but not restricted to, liaising with their primary care provider and the regional Long Covid clinic.


 
Back
Top Bottom